Related Experiment Videos
Serum interleukin 2 activity in renal graft recipients
G Sunder-Plassmann1, F Stockenhuber, P Balcke
1First Medical Clinic, University of Vienna, Austria.
Transplantation Proceedings
|June 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pathophysiology and Treatment of Hyperhomocysteinemia in End-Stage Renal Disease Patients.
Hemodialysis international. International Symposium on Home Hemodialysis·2017
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
Clinical pharmacology and therapeutics·2016
[Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
Medizinische Klinik, Intensivmedizin und Notfallmedizin·2016
[Probiotics for the prevention of antibiotic-induced diarrhea].
Zeitschrift fur Gastroenterologie·2012
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data.
Lancet (London, England)·2009
An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
The pharmacogenomics journal·2009
Intravascular Large B-Cell Lymphoma After Kidney Transplantation: A Rare Form of Post-Transplant Lymphoproliferative Disorder.
Transplantation proceedings·2026
Long-Term Outcomes of Heart Transplantation Using Hepatitis C-Positive Donors.
Transplantation proceedings·2026
Long-Term Outcomes of Renal Transplantation in Patients with Cystinosis.
Transplantation proceedings·2026
Changes and predictors of symptoms in unrelated hematopoietic stem cell donors: A longitudinal study.
Journal of psychosomatic research·2026